Company News: BellaSeno Establishes GMP-Compliant High-Throughput Additive Manufacturing Facility for Resorbable Medical Implants

– Seamless transition from R&D to commercial-scale additive manufacturing

– Leading-edge cleanroom, no-touch manufacturing

– GMP capabilities for internal and contract manufacturing

BellaSeno GmbH, an ISO 13485-certified medtech company developing absorbable scaffolds using additive manufacturing technologies, today announced the establishment of a novel, leading-edge additive manufacturing facility for medical implants supported by the Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig, Germany.

Read more…

Company News: Cardior Pharmaceuticals Announces Positive Phase Ib Results of its Lead Compound CDR132L in Heart Failure

— First-in-class compound showed excellent tolerability and safety

— Unique mode of action in chronic heart failure confirmed by data on cardiac function and biomarkers

— Phase II studies in subacute and chronic heart failure planned

Cardior Pharmaceuticals GmbH, a clinical-stage biotech company focused on the development of non-coding RNA (ncRNA) based therapeutics for patients with cardiovascular diseases, announced today positive results of a Phase Ib study with its lead compound CDR132L. Read more…

Company News: Cardior Pharmaceuticals´ Lead Compound Demonstrates Improvement of Heart Function in Chronic Heart Failure Model

— Safety and efficacy of CDR132L established in an in vivo model of chronic post-MI heart failure

— Study by international research team published in European Heart Journal

— Broad treatment potential for chronic heart failure

Cardior Pharmaceuticals GmbH, a clinical-stage biotech company, focused on the development of noncoding RNA (ncRNA) therapeutics for patients with cardiovascular diseases, today announced a publication in the European Heart Journal (doi:10.1093/eurheartj/ehaa791) demonstrating that repeated treatment with its lead compound CDR132L is safe, improves cardiac function and reduces both ventricular as well as left atrial volumes in chronic heart failure. Read more…

Company News: Heraeus PALACADEMY® offers new online training courses for orthopaedic infection management and prevention

– New live webinar

– New Science Cast series

Heraeus PALACADEMY®, the educational platform of Heraeus Medical, features new online events on infection management in orthopaedics and traumatology with a focus on the prevention and management of periprosthetic joint infections and the relevance of local antibiotics.

Webinar as Live TV Event (submitted for CME credits) Read more…

1 2 3 154